Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 3
- Countries
- 0
Exclusivity
Patents and exclusivities
3| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10839960 | MYDCOMBIphenylephrine hydrochloride; tropicamide | use | Jul 2031 |
| 11398306 | MYDCOMBIphenylephrine hydrochloride; tropicamide | use | Jul 2031 |
| 11839487 | MYDCOMBIphenylephrine hydrochloride; tropicamide | use | Jul 2031 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | suspension/ drops, ophthalmic | 81046-0319NDA |
Compare
Other companies listing clobetasol propionate
- Zydus Lifesciences Limited12 sites · 717 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Henan Lihua Pharmaceutical Co Ltd2 sites · 32 NDC
- Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
- Direct Rx1 site · 554 NDC
- Professional Compounding Centers of America dba PCCA1 site · 487 NDC
- Farmabios S.p.A.1 site · 69 NDC
- Symbiotica Speciality Ingredients Sdn. Bhd1 site · 36 NDC
Enquiry
Common questions
- Is Eyenovia, Inc. FDA approved?
- Eyenovia, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Eyenovia, Inc. make?
- 1 product is listed under Eyenovia, Inc. in the openFDA NDC Directory, most often as suspension/ drops. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.